CNS Pharmaceuticals, Inc. is a preclinical stage pharmaceutical company, which engages in the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. Its product pipeline includes berubicin, and CNS-12. The company was founded by Waldemar Priebe in July 2017 and is headquartered in Houston, TX.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
5
Frequently Asked Questions
What is Market Cap of Cns Pharmaceuticals Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Cns Pharmaceuticals Inc market cap is $5.1M.
What is the 52-week high for Cns Pharmaceuticals Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Cns Pharmaceuticals Inc 52 week high is $221.94 as of October 03, 2025.
What is the 52-week low for Cns Pharmaceuticals Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Cns Pharmaceuticals Inc 52 week low is $4.93 as of October 03, 2025.
What is Cns Pharmaceuticals Inc stock price today?
Cns Pharmaceuticals Inc stock price today is $8.81.
What was Cns Pharmaceuticals Inc stock price yesterday?
Cns Pharmaceuticals Inc stock price yesterday was $8.88.
What is the PE ratio of Cns Pharmaceuticals Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Cns Pharmaceuticals Inc’s P/E ratio is -0.04.
What is the Price-to-Book ratio of Cns Pharmaceuticals Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Cns Pharmaceuticals Inc P/B ratio is 0.3413.
What is the 50-day moving average of Cns Pharmaceuticals Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Cns Pharmaceuticals Inc 50-day moving average is $7.37.
How many employess does Cns Pharmaceuticals Inc has?